DCAP: The Effect of Diet Composition on Performance, Expenditure, Blood Lipids, and Appetite Hormones in Highly Trained Cyclists

Sponsor
Texas Christian University (Other)
Overall Status
Completed
CT.gov ID
NCT04097171
Collaborator
(none)
34
1
2
4.6
7.4

Study Details

Study Description

Brief Summary

This study employs a crossover design to evaluate the effect of two different diets (high carbohydrate vs. ketogenic) and corresponding test meals on endurance exercise performance, energy expenditure including resting metabolic rate and thermic effect of food, postprandial responses of blood lipids, glucose and appetite hormones, and cognitive function and mood states.

Condition or Disease Intervention/Treatment Phase
  • Other: Diet
N/A

Detailed Description

Traditionally, a high carbohydrate diet is recommended for elite endurance athletes and sub-elite, highly trained recreational athletes competing in endurance events. However, recently the ketogenic diet (extremely low carbohydrate content) has become popular in these populations. The effect on endurance exercise performance, energy expenditure, postprandial blood profiles, and cognitive function and mood states requires further investigation.

In this study, highly trained recreational cyclists and triathletes will adhere to each diet (high-carbohydrate and ketogenic) for 14 days in a crossover design. Experimental trials at baseline and after each diet will evaluate endurance cycling performance (time trial), resting energy expenditure, the thermic effect of food of test meals corresponding in composition to each diet, postprandial responses of blood lipids, glucose and appetite hormones, and cognitive function and mood states.

Study Design

Study Type:
Interventional
Actual Enrollment :
34 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
The Effect of Diet Composition on Performance, Energy Expenditure, Blood Lipids and Lipoproteins, and Cognitive Function and Mood States in Highly Trained Cyclists
Actual Study Start Date :
Nov 11, 2019
Actual Primary Completion Date :
Mar 30, 2020
Actual Study Completion Date :
Mar 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: High Carbohydrate Diet

Participants will consume a high carbohydrate diet (65-75% of total energy intake). Protein intake will be standardized at 15% of total energy intake.

Other: Diet
Participants will consume each diet for 14 days in a crossover design.

Experimental: Ketogenic Diet

Participants will consume a low carbohydrate diet (<5-10% of total energy intake). Protein intake will be standardized at 15% of total energy intake.

Other: Diet
Participants will consume each diet for 14 days in a crossover design.

Outcome Measures

Primary Outcome Measures

  1. Endurance Cycling Performance [180 min after the meal begins]

    Time to completion in a 30-kilometer simulated time trial

Secondary Outcome Measures

  1. Respiratory Exchange Ratio [Change from baseline at 30 min, 60 min, 90 min, 120 min, 150 min, 180 min, 192 min, 204 min, 216 min, 228 min and 240 min after the meal begins]

    Indirect calorimetry fasted, postprandial, and during exercise

  2. Muscle Fuel Rating [Change from baseline at 180 min and 240 min after the meal begins]

    Ultrasound echogenicity of Rectus Femoris

  3. Oxygen consumption (VO2) [At 192 min, 204 min, 216 min, 228 min and 240 min after the meal begins]

    Indirect calorimetry during exercise

  4. Rating of Perceived Exertion (RPE) [At 192 min, 204 min, 216 min, 228 min and 240 min after the meal begins]

    6-20 Borg's scale during exercise

  5. Thermic Effect of Food (postprandial energy expenditure) [Change from baseline at 30 min, 60 min, 90 min, 120 min, 150 min, 180 min after the meal begins]

    Fasted vs. postprandial indirect calorimetry

  6. Subjective appetite ratings [Change from baseline at 60 min, 120 min, 180 min after the meal begins]

    Visual Analog Scale (Scale 1: Perception of Hunger [0-100 mm]; Scale 2: Perception of Fullness [0-100 mm]; Scale 3: Desire to Eat [0-100 mm]

  7. Appetite hormones including ghrelin, leptin, insulin, and Peptide-YY [Change from baseline at 30 min, 60 min, 120 min, 180 min and 240 min]

    Fasted, postprandial & post exercise blood concentration of appetite hormones

  8. Blood glucose [Change from baseline at 180 min and 240 min after the meal begins; on day 7 of each diet]

    Fasted, postprandial & post exercise blood concentration of glucose

  9. Blood pressure [Change from baseline at 180 min after the meal begins]

    Fasted, postprandial & post exercise

  10. Cognitive function [At 180 min and 240 min after the meal begins]

    Stroop test

  11. Mood state questionnaire [At 180 min and 240 min after the meal begins]

    Abbreviated Profile of Mood States; 40-item scale; Likert scale from 0 = "not at all" to 4 = "extremely"

  12. Resting Metabolic Rate [At baseline before meal begins]

    Indirect calorimetry in fasted state

  13. Blood lipids including (triglycerides, total cholesterol, low density lipoprotein, and high-density lipoprotein) [Change from baseline at 30 min, 60 min, 120 min, 180 min, 192 min, 204 min, 216 min, 228 min and 240 min after the meal begins]

    Fasted and postprandial in mg/dL

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 100-150km of cycling per week

  • VO2max > 80th percentile for sex and age (adjusted for cycle ergometry)

  • apparently healthy

Exclusion Criteria:
  • weight loss supplements/medications/diet

  • extreme dietary patterns (e.g. extremely high or low carbohydrate)

  • nicotine use

  • heavy alcohol use (>7 drinks/week female; >14 drinks/week male)

  • food allergies

  • diabetes

  • heart disease

  • stroke

  • liver/kidney/thyroid disease

  • anemia

  • eating disorders

  • uncontrolled hypertension

  • pulmonary/orthopedic/musculoskeletal problems that prevent exercise

  • surgery that affects swallowing and digestion

  • claustrophobia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Texas Christian University Fort Worth Texas United States 76129

Sponsors and Collaborators

  • Texas Christian University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Meena Shah, Interim Chair, Professor and Director, Graduate Program, Texas Christian University
ClinicalTrials.gov Identifier:
NCT04097171
Other Study ID Numbers:
  • CT2019MS3
First Posted:
Sep 20, 2019
Last Update Posted:
Oct 5, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 5, 2021